Mindfulness meditation trial helps chronic neuropathic pain patients cope better
A Shepherd Center pilot tested whether mindfulness could help chronic neuropathic pain patients cope better, with patients using the skills in everyday stress moments.
A customer-service call and a rush-hour commute became the kind of real-world test cases Shepherd Center wanted from its mindfulness pilot for chronic neuropathic pain. The point was not to sell mindfulness as a cure, but to see whether training could help people cope better with pain and protect health-related quality of life.
The study, funded by the Samsky Spine and Pain Research Fund, focused first on feasibility and acceptability before chasing bigger claims about outcomes. Shepherd Center said the fund was launched in January 2023 to advance chronic and interventional pain management, research and treatment under Augustine Lee, M.D., who now leads the center’s chronic pain research efforts. The work sits inside a broader research push at Shepherd Center in Atlanta, Georgia, where the Spine and Pain Institute is running multiple clinical trials for pain secondary to spinal cord injury, neuropathic pain and other complex pain syndromes.
Two participants made the trial feel less like an abstract behavioral study and more like a tool people might actually keep using. Elizabeth Wilcox, who has lived with chronic pain since breaking three vertebrae and sustaining other injuries in a fall about eight years ago, said she used yoga and mindfulness during a frustrating customer-service call. Paul Fleming used box breathing to reset after morning rush-hour traffic. Those examples matter because they show the practice leaving the clinic and entering the ordinary friction of daily life, which is where chronic pain patients often need help most.
That practical angle lines up with the wider evidence base, which still treats mindfulness as symptom management rather than a standalone fix. A 2024 systematic review found mindfulness-based interventions reduced pain intensity in six trials, improved non-sensory pain dimensions in ten trials and lowered opioid consumption in four mindfulness-based trials. A 2016 systematic review and meta-analysis found low-quality evidence of a small drop in pain, along with possible gains in depression symptoms and quality of life. Other studies have pointed in the same direction, including a 2020 trial that found a four-week mindfulness program for adults with chronic pain was feasible and acceptable, a 2022 randomized trial comparing hypnosis, mindfulness meditation and education, and a 2022 study of an eight-week mindfulness-based stress reduction program in breast cancer survivors with chronic neuropathic pain.
For patients living with nerve pain, the clearest takeaway is narrow but useful: mindfulness is being tested as a low-cost coping skill that may help steady pain flares, stress and daily function. Anyone considering it should ask a clinician whether it can fit alongside current treatment, what form of breathing or meditation is safest for their symptoms and how to judge whether it is helping in everyday life.
This article was produced by Prism’s automated news system from verified source data, official records, and press releases, then run through automated quality and moderation checks before publishing. The system is built and supervised by the people who set the standards it runs under. Read our full AI policy.
Did this article answer your question?
